Concert Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Concert Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-11,707	Closed	-$780K	–	937
2016 Q3	$780K	Sell	11,707 -74	-0.6%	-$4.58K	0.09%	274
2016 Q2	$637K	Buy	11,781 +6,124	+108%	+$336K	0.09%	291
2016 Q1	$290K	Sell	5,657 -1,446	-20%	-$75.1K	0.04%	464
2015 Q4	$498K	Sell	7,103 -298	-4%	-$20.3K	0.07%	359
2015 Q3	$463K	Sell	7,401 -9,477	-56%	-$747K	0.06%	379
2015 Q2	$1.42M	Buy	16,878 +3,048	+22%	+$237K	0.18%	139
2015 Q1	$392K	Sell	13,830 -1,629	-11%	-$114K	0.11%	247
2014 Q4	$964K	Buy	15,459 +7,734	+100%	+$441K	0.15%	182
2014 Q3	$403K	Sell	7,725 -603	-7%	-$30.7K	0.05%	319
2014 Q2	$417K	Sell	8,328 -6,699	-45%	-$302K	0.05%	330
2014 Q1	$692K	Buy	15,027 +8,235	+121%	+$422K	0.09%	203
2013 Q4	$295K	Sell	6,792 -2,997	-31%	-$124K	0.04%	383
2013 Q3	$423K	Buy	+9,789	New	+$397K	0.06%	289

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Concert Wealth Management's XBI Position: Q4 2016 in Review

Concert Wealth Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2016, closing a stake of 11,707 shares — an estimated $780K sold.

Concert Wealth Management first reported a position in XBI in Q3 2013 and held it in 13 quarters. The position peaked at $1.42M in Q2 2015. 274 funds tracked by Wall St. Rank hold XBI as of Q4 2016.

Concert Wealth Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2016 after selling out during the quarter.
Concert Wealth Management sold 11,707 State Street SPDR S&P Biotech ETF shares in Q4 2016, an estimated $780K.
Concert Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2013 and held it in 13 quarters.
Concert Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $1.42M in Q2 2015.
274 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2016.

Based on Concert Wealth Management's 13F filing for Q4 2016, filed 10 Feb 2017.